A-Blocks can be developed or incorporated into numerous products.
It is anticipated that A-Blocks products will prevent and treat infections in a wide variety of medical settings.
These advanced biological polymers can be formulated as hydrogels, solutions, emulsions, or dressings and can act alone or enhance the performance of approved active pharmaceutical ingredients (APIs). Amicrobe is developing additional A-Blocks-based products to address unmet needs in human and veterinary medicine, including catheter-associated urinary tract infections and canine otitis externa. In these and other settings, A-Blocks-based products provide a non-antibiotic antimicrobial that is designed to be broadly active against a variety of bacteria (including resistant strains), fill and coat tissues, and be safe.
Amicrobe pledges its commitment to the highest standards of science, medicine, and business
This work is supported in part by the US Army Medical Research and Materiel Command through the Military Burn Research Program under Award No. W81XWH-15-2-0065 and by the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program under Award No. W81XWH-16-1-0561.. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.
© 2016 by Amicrobe, Inc.